Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2017

01-01-2017 | Original paper

Intimate partner violence and women’s cancer quality of life

Authors: Ann L. Coker, Diane R. Follingstad, Lisandra S. Garcia, Heather M. Bush

Published in: Cancer Causes & Control | Issue 1/2017

Login to get access

Abstract

Purpose

Because intimate partner violence (IPV) may disproportionately impact women’s quality of life (QOL) when undergoing cancer treatment, women experiencing IPV were hypothesized to have (a) more symptoms of depression or stress and (b) lower QOL as measured with the Functional Assessment of Cancer Therapy (FACT-B) and Functional Assessment of Chronic Illness Therapy—Spiritual Well-being (FACIT-SP) Scales relative to those never experiencing IPV.

Methods

Women, aged 18–79, who were included in one of two state cancer registries from 2009 to 2015 with a recent incident, primary, invasive biopsy-confirmed cancer diagnosis were recruited and asked to complete a phone interview, within 12 months of diagnosis. This interview measured IPV by timing (current and past) and type (physical, sexual, psychological), socio-demographics, and health status. Cancer registries provided consenting women’s cancer stage, site, date of diagnosis, and age.

Results

In this large cohort of 3,278 women who completed a phone interview, 1,221 (37.3%) disclosed lifetime IPV (10.6% sexual, 24.5% physical, and 33.6% psychological IPV). Experiencing IPV (particularly current IPV) was associated with poorer cancer-related QOL defined as having more symptoms of depression and stress after cancer diagnosis and lower FACIT-SP and FACT scores than women not experiencing IPV and controlling for confounders including demographic factors, cancer stage, site, and number of comorbid conditions. Current IPV was more strongly associated with poorer QOL. When compared with those experiencing past IPV (and no IPV), women with cancer who experienced current IPV had significantly higher depression and stress symptoms scores and lower FACIT-SP and FACT-G scores indicating poorer QOL for all domains. While IPV was not associated with being diagnosed at a later cancer stage, current IPV was significantly associated with having more than one comorbid physical conditions at interview (adjusted rate ratio = 1.35; 95% confidence interval 1.19–1.54) and particularly for women diagnosed with cancer when <55 years of age.

Conclusions

Current and past IPV were associated with poorer mental and physical health functioning among women recently diagnosed with cancer. Including clinical IPV screening may improve women’s cancer-related QOL.
Literature
1.
Logan TK, Walker R, Jordan CE et al (2006) Women and victimization: contributing factors, interventions, and implications. American Psychological Association, WashingtonCrossRef
2.
Coker AL, Williams C, Follingstad D et al (2011) Psychological, reproductive and maternal health, behavioral and economic impact. In: White JW, Koss MP, Kazdin AE (eds) Violence against women and children: consensus, critical analyses, and emergent priorities. Volume I: mapping the terrain. American Psychological Association, Washington, pp 265–284CrossRef
3.
Modesitt SC, Gambrell AC, Cottrill HM et al (2006) Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer. Obstet Gynecol 107:1330–1336CrossRefPubMed
4.
Coker AL, Follingstad D, Garcia LS et al (2012) Association of intimate partner violence and childhood sexual abuse with cancer-related well-being in women. J Women’s Health 21:1180–1188CrossRef
5.
6.
Black MC, Basile KC, Breiding MJ et al (2011) The National Intimate Partner and Sexual Violence Survey (NIDVS): 2010 summary report. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta
7.
Coker AL, Hopenhayn C, DeSimone CP, Bush HM, Crofford L (2009) Violence against women raises risk of cervical cancer. J Women’s Health 18(8):1179–1185CrossRef
8.
Golding JM (1999) Intimate partner violence as a risk factor for mental disorders: a meta-analysis. J Fam Viol 14:99–132CrossRef
9.
Baum A, Trevino LA, Dougall AJL (eds) (2011) Stress and cancers. Springer, New York
10.
Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361CrossRefPubMed
11.
Denaro N, Tomasello L, Russi EG (2014) Cancer and stress: what’s matters? From epidemiology: the psychologist and oncologist point of view. J Cancer Ther Res 3:1–11CrossRef
12.
Afifi TO, MacMillan HL, Boyle M, Cheung K, Taillieu T, Turner S, Sareen J (2016) Child abuse and physical health in adulthood. Health Rep 27(3):10–18PubMed
13.
Hathaway JE, Mucci LA, Silverman JG et al (2000) Health status and health care use of Massachusetts women reporting partner abuse. Am J Prev Med 19:302–307CrossRefPubMed
14.
15.
Farley MS, Golding JA, Minkoff JR (2002) Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract 51:827–831PubMed
16.
Loxton D, Powers J, Schofield M et al (2009) Inadequate cervical cancer screening among mid-aged Australian women who have experienced partner violence. Prev Med 48:184–188CrossRefPubMed
17.
18.
19.
Lemon SC, Verhoek-Oftedahl W, Donnelly EF (2002) Preventive healthcare use, smoking, and alcohol use among Rhode Island women experiencing intimate partner violence. J Women’s Heath 11(6):555–562
20.
Coker AL, Bond SM, Pirisi LA (2006) Life stressors are an important reason for women discontinuing follow-up care for cervical neoplasia. Cancer Epidemiol Biomarkers 15:321–325CrossRef
21.
Martino MA, Balar A, Cragun JM et al (2005) Delay in treatment of invasive cervical cancer due to intimate partner violence. Gynecol Oncol 99:507–509CrossRefPubMed
22.
Kimerling R, Alvarez J, Pavao J et al (2009) Unemployment among women examining the relationship of physical and psychological intimate partner violence and posttraumatic stress disorder. J Interpers Violence 24:450–463CrossRefPubMed
23.
Coker AL, Smith PH, Thompson MP et al (2002) Social support protects against the negative effects of partner violence on mental health. J Women’s Health 11:465–476
24.
Curry MA, Hassouneh-Phillips D et al (2001) Abuse of women with disabilities—an ecological model and review. Violence Against Women 7:60–79CrossRef
25.
26.
Campbell JC, Kub J, Belknap RA et al (1997) Predictors of depression in battered women. Violence Victims 3:271–293
27.
Johnson W, Pieters HC (2016) Intimate partner violence among women diagnosed with cancer. Cancer Nurs 39(2):87–96CrossRefPubMed
28.
Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB (1996) The revised conflict tactics scales: development and preliminary psychometric data. J Fam Issues 17:283–316CrossRef
29.
Follingstad DR (2011) A measure of severe psychological abuse normed on a nationally representative sample. J Interpers Violence 26:1194–1214CrossRefPubMed
30.
Follingstad DR, Coker AL, Lee E, Willimas CM, Bush HM, Mendiondo MM (2015) Validity and psychometric properties of the measure of psychologically abusive behaviors among young women and women in distressed relationships. Violence Against Women 21(7):875–896CrossRefPubMed
31.
Bonomi AE, Anderson ML, Reid RJ, Carrett D, Fishman PA, Rivara FP, Thompson RS (2007) Intimate partner violence in older women. Gerontologist 47(1):34–41CrossRefPubMed
32.
Smith PH, Earp JA, DeVellis R (1995) Measuring battering: development of the Women’s Experience With Battering (WEB) Scale. Women’s Health 1:273–288PubMed
33.
Derogatis LR, Lazarus L (2001) Brief symptom inventory 18: administration, scoring and procedures manual. NCS Pearson, Inc., Minneapolis, MN
34.
Cohen S, Kamarck T, Mermelstein R (1983) A Global measure of perceived stress. J Health Soc Behav 24:385–396CrossRefPubMed
35.
Peterman AH, Fitchett G, Brady MJ et al (2002) Measuring spiritual well-being in people with cancer: the Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 24:49–58CrossRefPubMed
36.
Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
37.
38.
Coker AL, Follingstad DR, Garcia LS, Bush HM (2016) Partner interfering behaviors affecting cancer quality of life. Psycho-oncology. doi:10.​1002/​pon.​4157
39.
MacMillan HL, Wathen CN, Jamieson E et al (2009) Screening for intimate partner violence in health care settings: a randomized trial. JAMA 302:493–501CrossRefPubMed
40.
McFarlane JM, Groff JY, O’Brien JA et al (2006) Secondary prevention of intimate partner violence: a randomized controlled trial. Nurs Res 55:52–61CrossRefPubMed
41.
Institute of Medicine (2011) Clinical preventive services for women: closing the gaps. The National Academies Press, Washington
42.
Moyer VA, Force UPST (2013) Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement. Ann Intern Med 158:1–28CrossRef
43.
McFarlane J, Malecha A, Gist J et al (2002) An intervention to increase safety behaviors of abused women—results of a randomized clinical trial. Nurs Res 51:347–354CrossRefPubMed
44.
Cesario SK, McFarlane J, Nava A et al (2013) Linking cancer and intimate partner violence: the importance of screening women in the Oncology setting. Clin J Oncol Nurs 18:65–73CrossRef
Metadata
Title
Intimate partner violence and women’s cancer quality of life
Authors
Ann L. Coker
Diane R. Follingstad
Lisandra S. Garcia
Heather M. Bush
Publication date
01-01-2017
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 1/2017
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0833-3

Other articles of this Issue 1/2017

Cancer Causes & Control 1/2017 Go to the issue

Original Paper

Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation

Commentary

Sex differences in the association of obesity and colorectal cancer risk

Original paper

Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort

Original paper

Trends in published meta-analyses in cancer research, 2008–2013

Original paper

Diabetes and breast cancer mortality in Black women

Brief report

Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits